6 COVID-19 treatments helping patients survive
A year ago, when U.S. health authorities issued their first warning that COVID-19 would cause severe “disruption to everyday life,” […]
(HealthDay)—Patients with type 2 diabetes mellitus (T2DM) have a reduced risk for rheumatoid arthritis (RA), which may be due to […] Hormone therapy commonly is given as a targeted treatment for women whose cancer cells carry receptors for estrogen. But the […] Based on a systematic review of scientific studies dating back nearly 70 years, researchers at Johns Hopkins Medicine and collaborating […] Experts have a simple answer for heart and stroke patients questioning whether they need a COVID-19 vaccination. That answer: yes. […] Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of […] (HealthDay)—Could a cancer diagnosis sometimes produce positive life changes? In a new study, many people with colon cancer, even in […] Hundreds of cancer patients have benefitted from using computer algorithms to manage their symptoms and improve their wellbeing in a […] In an in-depth study of how COVID-19 affects a patient’s brain, National Institutes of Health researchers consistently spotted hallmarks of […] 21 December 2020 — AstraZeneca’s Tagrisso (osimertinib) has been approved in the US for the adjuvant treatment of adult patients with early-stage […]patients
Risk for rheumatoid arthritis reduced for patients with T2DM
Imaging identifies breast cancer patients unlikely to benefit from hormone therapy
Looking back decades shows hospitalized patients need more than movement to prevent dangerous clots
What heart and stroke patients should know about COVID-19 vaccines
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
For many cancer patients, diagnosis brings psychological ‘silver lining’
New tech helping cancer patients manage symptoms
Brain damage of patients with Covid-19
Tagrisso Approved in the US for the Adjuvant Treatment of Patients with Early-Stage EGFR-Mutated Non-Small Cell Lung Cancer